Cambrex acquires manufacturing

Published: 27-Jul-2001


Cambrex has bought Bio Science Contract Production's biopharmaceutical manufacturing business, based in Baltimore, MD, US. The business involves the cGMP manufacture of purified bulk biologics and pharmaceutical ingredients. The facility containes four bioprocessing and purification suites for products including recombinant proteins, enzymes, plasmid DNA, monoclonal antibodies and vaccines for clinical and commercial requirements.

You may also like